A New Dawn in Cardio & Vascular Protection

Friday 26th September 2008

A New Dawn in Cardio & Vascular Protection

Barcelona, Spain

The following presentations made in Barcelona, Spain are available as webcasts under the respective links:

Welcome and opening remarks

Salim Yusuf, Canada, and Michael Böhm, Germany

ONTARGET^®: The journey

Thomas Unger, Germany

TRANSCEND^®

Salim Yusuf, Canada

ONTARGET^®: The Results

Gilles Dagenais, Canada

Question & Answers

All

In focus: Protecting patients with cardiovascular diseases

ONTARGET^®: The population

Michael Böhm, Germany

Who should be ONTARGET^®?

Peter Sleight, United Kingdom

In focus: Protecting patients with hypertension

Target: the importance of 24 h blood pressure lowering

Thomas Pickering, United States

Different patients – same target?

Giuseppe Mancia, Italy

In focus: Maximising patient benefit

Treatment for Life

Sarah Jarvis, United Kingdom

Persistency: no drug, no protection

Giuseppe Mancia, Italy

Panel Discussion

All

Session close

Michael Böhm, Germany

^* Telmisartan is currently only approved for the treatment of hypertension

These webcasts follow the presentations held on occasion of the Stand Alone Meeting between 25th - 28th September 2008. They are reproduced here for your personal information. Pursuant to our Terms of Use any sort of reproduction or downloading, in total or in part, is prohibited.